ScreenerHero

AYR-AAyr Wellness Inc.

CNQ · CA · Healthcare · Drug Manufacturers - Specialty & Generic · ayrwellness.com
0.1550CAD0.00%Mkt Cap: 13.18M $P/E: —

Ayr Wellness Inc. cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods in United States. The company engages in the possession, manufacture, use, sale, or distribution of cannabis a…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$62.66BUSDP/E 24.3
TAK
Takeda Pharmaceutical Company Limited
$60.33BUSD
TEVA
Teva Pharmaceutical Industries Limited
$46.72BUSDP/E 66.8
HLN
Haleon plc
$41.16BUSDP/E 19.5
ZTS
Zoetis Inc.
$29.48BUSDP/E 11.6
ZOE
Zoetis Inc.
$27.77BUSDP/E 11.6
UTHR
United Therapeutics Corporation
$21.22BUSDP/E 17.7
VTRS
Viatris, Inc.
$19.47BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.80BUSDP/E 112.9
NBIX
Neurocrine Biosciences, Inc.
$14.63BUSDP/E 21.0
IPN
Ipsen S.A.
$13.27BUSDP/E 24.0
ELAN
Elanco Animal Health Incorporated
$11.20BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.33BUSDP/E 30.2
KRK
Krka, d. d.
$8.66BUSDP/E 18.8
ALKS
Alkermes plc
$7.41BUSDP/E 116.3
AMRX
Amneal Pharmaceuticals, Inc.
$7.02BUSDP/E 42.0
HIMS
Hims & Hers Health, Inc.
$6.85BUSD
LNTH
Lantheus Holdings, Inc.
$6.55BUSDP/E 24.0
KNSA
Kiniksa Pharmaceuticals International, plc
$6.10BUSDP/E 78.9
LQDA
Liquidia Corporation
$5.95BUSDP/E 47.5

Key Statistics

Company
Market Cap13.18M $
Enterprise Value436.81M $
Revenue (TTM)329.83M $
Gross Profit128.67M $
Net Income (TTM)-261.67M $
Revenue/Share2.854 USD
Last Price0.1550 CAD
Fiscal Year EndDec 2024
MR QuarterMar 2025
Employees2.5K
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA05475P1099
Valuation
P/E (Trailing)—
P/E (Forward)-0.12
PEG—
EV/EBITDA29.58
EV/Revenue1.32
P/S0.04
P/B0.04
EPS (TTM)-4.45
EPS (Forward)-1.29
52W Range
—
52W High0.1550 CAD
52W Low0.1550 CAD
Profitability
Gross Margin38.11%
Oper. Margin-18.45%
EBITDA Margin4.48%
Profit Margin-77.50%
ROE-94.67%
ROA-28.31%
Growth
Revenue Growth-9.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF7.01M $
CapEx (TTM)18.04M $
FCF Margin7.22%
FCF Yield180.73%
Net Debt434.54M $
Net Debt/EBITDA29.43
Balance Sheet
Debt/Equity1.64
Current Ratio0.49
Quick Ratio0.14
Book Value/Sh3.845 CAD
Cash/Share0.3220 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.108.76M
Float113.06M
Insiders9.75%
Institutions0.68%
Short Interest
Shares Short3.99K
Short (prev mo.)3.99K
Technical
SMA 500.1550 (+0.0%)
SMA 2000.1550 (+0.0%)
Beta1.02
S&P 52W Chg14.29%
Avg Vol (30d)0
Avg Vol (10d)0
Technical Indicators
RSI (14)100.0
MACD0.0000
MACD Signal0.0000
MACD Hist.+0.0000
BB Upper0.1550 CAD
BB Middle0.1550 CAD
BB Lower0.1550 CAD
BB Width0.00%
ATR (14)0.0000 CAD
Vol Ratio (20d)—